Staff20192020202120222023
Personnel at the end of the year17414999110-
Staff turnover in EUR179,684203,664290,778233,982-
Turnover LabelEUREUREUREUREUR
The share: stated in EUR20192020202120222023
Shares outstanding (in mn.)44.8547.7556.723.040.00
Dividend per share-----
Basic earnings per share-0.15-0.220.66-0.77-
P/L in EUR million under IAS/IFRS20192020202120222023
Turnover31.330.328.825.70.0
Operating income (EBIT)-2.2-10.024.71.10.0
Earnings before taxes-4.8-12.721.01.00.0
Annual net profit/ loss-7.4-13.038.3-44.20.0
Balance sheet in EUR million under IAS/IFRS20192020202120222023
Assets
Total current assets22.526.114.415.10.0
Total fixed assets37.532.262.918.30.0
Total assets60.058.377.233.40.0
Liabilities
Total short-term liabilities11.68.317.58.40.0
Total long-term liabilities38.542.61.84.60.0
Total provisions0.00.00.00.00.0
Equity capital10.07.458.020.30.0
Total liabilities60.058.377.233.40.0
Management:
Pilar de la Huerta
Board:
Wilhelm Konrad Zours
Heikki Lanckriet
Helge Lubenow
Karin Lergenmüller
Jörgen Thielmann
Karlheinz Schmelig
Shareholding in %:
Arvernus Capital AG 0.01
Biofrontera, Inc. 9.97
Maruho Co., Ltd. 21.00
Freefloat 69.02
Address: Hemmelrather Weg 201, 51377 Leverkusen
T: +49-214-87-63-2-0
F: +49-214-87-63-2-90
I: http://biofrontera.com
E: info@biofrontera.com